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Background
Reporting a case of Severe combined immunodeficiency
syndrome with RAG1 mutation gene.
Methods
Analysis of medical records was conducted to obtain
detailed clinical history.
Results
ACOA, 3 months, female, born cesarean with 38 weeks.
She had the following vaccines: BCG, hepatitis B, VIP /
VOP, tetravalent rotavirus, pneumococcus and menigo-
coco. The patient had daily fever for 4 days, oliguria, dys-
pnea, and diarrhea with severe septic shock and
respiratory failure. The patient remained hospitalized in
intensive care for 50 days with tracheal intubation for
23 days. When she was 2 months old was hospitalized for
10 days with septic shock. Requested tests: CBC showing
lymphopenia ( 855), positive Rotavirus, hipogamoglubuli-
nemia ( IgG 143, IgM 9.7, IgA 26), absence of thymus
chest radiography and immunophenotyping with amend-
ment (Lymphocyte T - CD45/CD3 = 60 cells/mm3,
CD45/CD3/CD4 = 55celulas/mm3, CD45/CD3/CDCD8 =
5 cells/mm3, CD4/CD8 ratio = 11.00, B lymphocyte -
CD45/CD19 celula/mm3 = 1, NK-cells - CD45 / CD3-/
CD16 + / CD56 + = 89 cells/mm3).The results of these
tests made the diagnosis of severe combined immunodefi-
ciency syndrome (T-B-NK +)(SCID) associated with
homozygous mutation in the RAG-1 gene by sequencing
of SCID panel ,therapy was initiated with cefepime
trimethoprim-sulfamethoxazole, rifampin, isoniazid,
ethambutol, pyridoxine, fluconazole,zinc e PRBC. Initiate
treatment with human gamma globulin 400mg/kg intrave-
nously for 5 consecutive days and after this repeated doses
with intervals 21/21 days. The evolution was favorable ,
indicating bone marrow transplantation.
Conclusions
The Severe Combined Immunodeficiency is a pediatric
emergency and it is necessary to increase the clinical sus-
picion due to a quickly evolution to the death when the
treatment is not quickly started. The early diagnosis of the
patient in this case results in a better prognosis.
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